The E3 Ubiquitin Protein Ligase HERC2 Modulates the Activity of Tumor Protein p53 by Regulating Its Oligomerization

Mammalian HECT ubiquitin-protein ligases: Biological and pathophysiological aspects

(2013) Martin Scheffner et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Activation and control of p53 tetramerization in individual living cells

(2013) G. Gaglia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A homozygous missense mutation inHERC2associated with global developmental delay and autism spectrum disorder

(2012) Erik G. Puffenberger et al.   HUMAN MUTATION

Mutation of HERC2 causes developmental delay with Angelman-like features

(2012) Gaurav V Harlalka et al.   JOURNAL OF MEDICAL GENETICS

Mass Spectrometry: Reconnaissance at the Frontiers of Biology

(2012) Alma L. Burlingame et al.   MOLECULAR & CELLULAR PROTEOMICS

HERC2 Interacts with Claspin and Regulates DNA Origin Firing and Replication Fork Progression

(2011) N. Izawa et al.   CANCER RESEARCH

The Cullin7 E3 ubiquitin ligase: A novel player in growth control

(2011) Antonio Sarikas et al.   CELL CYCLE

Physical and Functional Interaction of the HECT Ubiquitin-protein Ligases E6AP and HERC2

(2011) Simone Kühnle et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

HERC2 Is an E3 Ligase That Targets BRCA1 for Degradation

(2010) W. Wu et al.   CANCER RESEARCH

Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris-acetate polyacrylamide gels

(2010) Monica Cubillos-Rojas et al.   ELECTROPHORESIS

p53 at a glance

(2010) C. A. Brady et al.   JOURNAL OF CELL SCIENCE

Genotype–phenotype associations and human eye color

(2010) Désirée White et al.   JOURNAL OF HUMAN GENETICS

Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase

(2010) T.-H. Kang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RING Domain E3 Ubiquitin Ligases

(2009) Raymond J. Deshaies et al.   Annual Review of Biochemistry

Bleomycin treatment of brain tumors: an evaluation

(2009) Mette Linnert et al.   ANTI-CANCER DRUGS

Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer

(2009) Koji Kawai et al.   CANCER SCIENCE

Blinded by the Light: The Growing Complexity of p53

(2009) Karen H. Vousden et al.   CELL

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes

(2009) Simon Bekker-Jensen et al.   NATURE CELL BIOLOGY

Physiological functions of the HECT family of ubiquitin ligases

(2009) Daniela Rotin et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Progressive Purkinje Cell Degeneration in tambaleante Mutant Mice Is a Consequence of a Missense Mutation in HERC1 E3 Ubiquitin Ligase

(2009) Tomoji Mashimo et al.   PLoS Genetics

The RCC1 superfamily: From genes, to function, to disease

(2008) Ouadah Hadjebi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

ERK and p38 pathways regulate amino acid signalling

(2008) Eduard Casas-Terradellas et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development

(2008) Francesca Bernassola et al.   CANCER CELL

Acetylation Is Indispensable for p53 Activation

(2008) Yi Tang et al.   CELL

Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B

(2008) K. Hochrainer et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation

(2008) Yoko Itahana et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The CUL7 E3 Ubiquitin Ligase Targets Insulin Receptor Substrate 1 for Ubiquitin-Dependent Degradation

(2008) Xinsong Xu et al.   MOLECULAR CELL

Molecular basis of Pirh2-mediated p53 ubiquitylation

(2008) Yi Sheng et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY